The founder of Insys Therapeutics, John Kapoor, and four colleagues face jail after a US court convicted them of a racketeering conspiracy where doctors were illegally induced to prescribe
Insys has declared bankruptcy, hard on the heels of its agreement last week to a $225 million payment to settle charges it bribed doctors to prescribe opioid painkillers.
Insys Therapeutics has agreed to pay a hefty $225 million to settle criminal and civil investigations into unlawful marketing practices – including kickbacks – to boost sales of an opioid p
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.